Citation Impact
Citing Papers
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
2013 StandoutScience
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Untangling the ErbB signalling network
2001 Standout
Astrocytes: biology and pathology
2009 Standout
Intellectual impairment in neurofibromatosis 1
1996
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Genetic analysis of NF1: Identification of close flanking markers on chromosome 17
1987
Elevated Risk for MPNST in NF1 Microdeletion Patients
2003
Deletion of the entire NF1 gene detected by FISH: Four deletion patients associated with severe manifestations
1995
Hearing preservation surgery for neurofibromatosis Type 2–related vestibular schwannoma in pediatric patients
2007
DNA duplication associated with Charcot-Marie-Tooth disease type 1A
1991 Standout
Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register service
2010 Standout
Inherited PAX6, NF1 and OTX2 mutations in a child with microphthalmia and aniridia
2007 StandoutNobel
Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients
2005
Genomic characterization of the Neurofibromatosis Type 1 gene of Fugu rubripes
1998
Tumor suppressor genes
1991 Standout
Therapeutic Efficacy of the Somatostatin Analog SMS 201-995 (Octreotide) in Acromegaly
1990
Immunoglobulins of Lambert‐Eaton myasthenic syndrome inhibit rat pituitary hormone release
1987
Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy
1990 Standout
Neurofibromatosis 1 (Recklinghausen Disease) and Neurofibromatosis 2 (Bilateral Acoustic Neurofibromatosis)
1990
Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP)
1998
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
2002 StandoutNobel
Neuroendocrine gastrointestinal tumours
1996
Guideline of transthyretin-related hereditary amyloidosis for clinicians
2013 Standout
Advances in the treatment of neurofibromatosis-associated tumours
2013
A CNS-permeable Hsp90 inhibitor rescues synaptic dysfunction and memory loss in APP-overexpressing Alzheimer’s mouse model via an HSF1-mediated mechanism
2016
Human immunodeficiency virus—associated myopathy: Analysis of 11 patients
1988
Epidemiology of Brain Tumors
2007
Fugu: a compact vertebrate reference genome
2000 StandoutNobel
Malignant Gliomas in Adults
2008 Standout
Repetitive DNA (TGGA)n 5′ to the human myelin basic protein gene: A new form of oligonucleotide repetitive sequence showing length polymorphism
1990 StandoutNobel
Listening to silence and understanding nonsense: exonic mutations that affect splicing
2002 Standout
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
2003
Generation and Analysis of 25 Mb of Genomic DNA from the Pufferfish Fugu rubripes by Sequence Scanning
1999 StandoutNobel
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
1993 Standout
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
1990 Standout
Characterization of three genes, AKAP84, BAW and WSB1, located 3′ to the Neurofibromatosis type 1 locus in Fugu rubripes
1999
Moderate and severe traumatic brain injury in adults
2008 Standout
Molecular diagnosis of neurofibromatosis type 1: 2 years experience
2006
Genetic Alterations during Colorectal-Tumor Development
1988 Standout
Polymyositis and dermatomyositis
2003 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Nociceptors: the sensors of the pain pathway
2010 StandoutNobel
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
2006 Standout
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy
2012
Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
2000
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Management of glioblastoma: State of the art and future directions
2020 Standout
Exosomes
2019 Standout
Pancreatic endocrine tumors: Immunocytochemical analysis of 125 tumors
1982
Yeast α factor is processed from a larger precursor polypeptide: The essential role of a membrane-bound dipeptidyl aminopeptidase
1983 StandoutNobel
Human somatostatin I: sequence of the cDNA.
1982
IgG from Patients with Lambert-Eaton Syndrome Blocks Voltage-Dependent Calcium Channels
1988 StandoutScienceNobel
Molecular pharmacology of somatostatin receptor subtypes
1997
Neurofibromatosis type 1 in Israel: survey of young adults.
1994
Eaton‐lambert myasthenic syndrome: Long‐term treatment of three patients with prednisone
1981
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies
2006
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Plasmapheresis and immunosuppressive drug therapy in the Eaton‐Lambert syndrome
1982
The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2
1997 Standout
Molecular, Genetic, and Cellular Pathogenesis of Neurofibromas and Surgical Implications
2005
Ultrastructural, immunohistochemical and biochemical studies on amylase and ACTH producing lung cancer
1985 StandoutNobel
Inherited Autonomic Neuropathies
2003
Somatostatin
1983
Small Molecule Modulators of Protein–Protein Interactions: Selected Case Studies
2014
Actinomycosis: Diagnostic and therapeutic considerations and a review of 32 cases
1984 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Proteomic Analysis Reveals Hyperactivation of the Mammalian Target of Rapamycin Pathway in Neurofibromatosis 1–Associated Human and Mouse Brain Tumors
2005
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
2008 Standout
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
1990 StandoutScience
Genitourinary Dysfunction in Multiple System Atrophy: Clinical Features and Treatment in 62 Cases
1994
Growth Factors and Cancer
1991 StandoutScience
DNA "fingerprints" and segregation analysis of multiple markers in human pedigrees.
1986
Autonomic dysfunction and Eaton Lambert syndrome
1985
Somatic mosaicism in a patient with neurofibromatosis type 1.
1996
Actinomycosis of the Head and Neck
1979
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Diabetic Autonomic Neuropathy
2003 Standout
Neurofibromatosis type 1 in children
1996
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
2013 Standout
Duodenal Somatostatinoma and Erythrocytosis in a Patient with Von Hippel-Lindau Disease Type 2A.
2001
Somatostatin and Somatostatin Analogue (SMS 201-995) in Treatment of Hormone-Secreting Tumors of the Pituitary and Gastrointestinal Tract and Non-Neoplastic Diseases of the Gut
1989
Second consensus statement on the diagnosis of multiple system atrophy
2008 Standout
Gene for von Recklinghausen Neurofibromatosis Is in the Pericentromeric Region of Chromosome 17
1987 Science
Somatostatin Mediation of Adenohypophysial Secretion
1986
Disorders of the autonomic nervous system: Part 1. Pathophysiology and clinical features
1987
The influence of heregulins on human Schwann cell proliferation
1995
Recent advances in neurofibromatosis type 1
2004
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
1989 StandoutScience
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
1984 Standout
Adverse Effects of Drugs on Muscle
1982
Works of Allan E. Rubenstein being referenced
The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization
1996
Synthesis of pochoxime prodrugs as potent HSP90 inhibitors
2009
Nerve growth factor receptors on dissociated neurofibroma Schwann-like cells.
1986
Somatostatinoma Syndrome
1979
Acute Hypokalemic Myopathy in Alcoholism
1977
Neurofibromatosis: A Review of the Clinical Problem
1986
Autonomic neuropathy associated with autoimmune disease
1985
The Novel Hsp90 Inhibitor NXD30001 Induces Tumor Regression in a Genetically Engineered Mouse Model of Glioblastoma Multiforme
2010
Plexiform neurofibromas in NF1
2002
Peripheral catecholamine depletion in amyloid autonomic neuropathy.
1979
Facial actinomycosis misdiagnosed as tetanus.
1959
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2
1997
Cholinergic dysautonomia and Eaton‐Lambert syndrome
1979
The Management of Shy-Drager Syndrome with Propantheline and Intermittent Self-Catheterization: A Case Report
1981
Linkage analysis of neurofibromatosis (von Recklinghausen disease).
1983
Schwann‐Like Cells Cultured from Human Dermal Neurofibromasa
1986
A novel small molecule HSP90 inhibitor, NXD30001, differentially induces heat shock proteins in nervous tissue in culture and in vivo
2013
Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients.
1994
The pupil in familial dysautonomia
1981